The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies

被引：2
|
作者：
Nath, Karthik [1 ]
Mailankody, Sham [1 ,2 ,3 ]
Usmani, Saad Z. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA
[3] Weill Cornell Med Coll, Dept Med, New York, NY USA
[4] Mem Sloan Kettering Cance, Adult Bone Marrow Transplant Serv, New York, NY USA
[5] 30 East 74th St,Room 20-228, New York, NY 10021 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
CAR T-cell therapy; Bispecific antibodies; Immunotherapeutic agents; Multiple myeloma; MULTIPLE-MYELOMA; MATURATION ANTIGEN; PLUS LENALIDOMIDE; PHASE-3; RISK; BCMA;
D O I：
10.1016/j.hoc.2023.05.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1201 / 1214
页数：14
相关论文
共 50 条
  • [41] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [42] Is Chimeric Antigen Receptor T-cell Therapy the Future of Autoimmunity Management?
    Tahir, Amber
    CUREUS, 2018, 10 (10):
  • [43] Parkinsonism Associated with Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy
    Schneider, Sabine
    Aamodt, Whitley W.
    Pruitt, Amy A.
    Berger, Joseph R.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (12): : 1625 - 1628
  • [44] Chimeric antigen receptor T-cell therapy in hematologic malignancies: Successes, challenges, and opportunities
    Ho, Matthew
    Zanwar, Saurabh
    Paludo, Jonas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 197 - 210
  • [45] Parkinsonism and Bilateral Facial Palsy after Chimeric Antigen Receptor T-Cell Therapy
    Wu, Annie Siyu
    Hophing, Lauren
    Gosse, Paula
    Motamed, Mehras
    Bhella, Sita Devi
    Stewart, Keith
    Fasano, Alfonso
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2025,
  • [46] Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma Moving Into the Spotlight
    Wang, Bo
    Rajeeve, Sridevi
    Madduri, Deepu
    CANCER JOURNAL, 2021, 27 (03) : 205 - 212
  • [47] Chimeric antigen receptor T cell therapy for multiple myeloma
    Hasegawa, Kana
    Hosen, Naoki
    INFLAMMATION AND REGENERATION, 2019, 39 (1)
  • [48] Chimeric antigen receptor T cell therapy for multiple myeloma
    Kana Hasegawa
    Naoki Hosen
    Inflammation and Regeneration, 39
  • [49] Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer
    Xu, Caili
    Ju, Dianwen
    Zhang, Xuyao
    ANTIBODY THERAPEUTICS, 2022, 5 (01) : 73 - 83
  • [50] Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy
    Shannon P. Fortin Ensign
    Charles Gaulin
    Maya Hrachova
    Michael Ruff
    Ehab Harahsheh
    Kevin Vicenti
    Januario Castro
    Javier Munoz
    Allison Rosenthal
    Maciej M. Mrugala
    Current Treatment Options in Oncology, 2022, 23 : 1845 - 1860
12345